Adriaan J. Van Der Meer

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 196 publications

Editorial: Beyond the Withdrawal-Why the POISE Long-Term Data Still Matter.

Editorial: Beyond the Withdrawal-Why the POISE Long-Term Data Still Matter.

Journal: Alimentary pharmacology & therapeutics
Published: July 24, 2026

Comparative performance of HCC risk scores in identifying low-risk patients with cirrhosis: A multicenter cohort study.

Comparative performance of HCC risk scores in identifying low-risk patients with cirrhosis: A multicenter cohort study.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: May 19, 2026

Editorial: UDCA Dosing in PBC-Between Guideline Adherence and Clinical Reality: Authors' Reply.

Editorial: UDCA Dosing in PBC-Between Guideline Adherence and Clinical Reality: Authors' Reply.

Journal: Alimentary pharmacology & therapeutics
Published: May 15, 2026

Continuous positive airway pressure in breast cancer radiotherapy: Protocol of a prospective clinical trial.

Continuous positive airway pressure in breast cancer radiotherapy: Protocol of a prospective clinical trial.

Journal: Clinical and translational radiation oncology
Published: April 03, 2026

Bezafibrate for primary biliary cholangitis: A number needed to treat analysis.

Bezafibrate for primary biliary cholangitis: A number needed to treat analysis.

Journal: JHEP reports : innovation in hepatology
Published: February 27, 2026

Letter: Association of Diabetes Mellitus With Post-TIPS Hepatic Encephalopathy in a Predominantly Viral Cirrhosis Cohort-Authors' Reply.

Letter: Association of Diabetes Mellitus With Post-TIPS Hepatic Encephalopathy in a Predominantly Viral Cirrhosis Cohort-Authors' Reply.

Journal: Alimentary pharmacology & therapeutics
Published: January 29, 2026

Management of Inflammatory Bowel Disease Associated With Primary Sclerosing Cholangitis Pre- and Post-liver Transplantation.

Management of Inflammatory Bowel Disease Associated With Primary Sclerosing Cholangitis Pre- and Post-liver Transplantation.

Journal: Transplantation
Published: January 28, 2026

Editorial: TIPS in the Era of Aging and Metabolic Comorbidity-Rethinking Risks and Rewards. Authors Reply.

Editorial: TIPS in the Era of Aging and Metabolic Comorbidity-Rethinking Risks and Rewards. Authors Reply.

Journal: Alimentary pharmacology & therapeutics
Published: December 30, 2025

A Nationwide Assessment of Anticholestatic Therapy Uptake in Patients With Primary Biliary Cholangitis: Opportunities for Optimisation.

A Nationwide Assessment of Anticholestatic Therapy Uptake in Patients With Primary Biliary Cholangitis: Opportunities for Optimisation.

Journal: Alimentary pharmacology & therapeutics
Published: November 13, 2025

Quantitative magnetic resonance cholangiopancreatography metrics improve prognostication in primary sclerosing cholangitis.

Quantitative magnetic resonance cholangiopancreatography metrics improve prognostication in primary sclerosing cholangitis.

Journal: JHEP reports : innovation in hepatology
Published: November 05, 2025

Validation of Quantitative Magnetic Resonance Cholangiopancreatography Metrics in Prediction of Transplant-free Survival in Primary Sclerosing Cholangitis.

Validation of Quantitative Magnetic Resonance Cholangiopancreatography Metrics in Prediction of Transplant-free Survival in Primary Sclerosing Cholangitis.

Journal: Journal of clinical and experimental hepatology
Published: September 06, 2025

Editorial: Lymphocyte-To-Monocyte Ratio and Recompensation in PBC-A New Piece in an Incomplete Puzzle?

Editorial: Lymphocyte-To-Monocyte Ratio and Recompensation in PBC-A New Piece in an Incomplete Puzzle?

Journal: Alimentary pharmacology & therapeutics
Published: June 24, 2025
Showing 1-12 of 196

Last Updated: 09/26/2026